These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 17280478)

  • 21. Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis.
    Storsaeter J; Hallander HO; Gustafsson L; Olin P
    Vaccine; 1998 Dec; 16(20):1907-16. PubMed ID: 9796042
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of FHA and Prn on Bordetella pertussis colonization of mice is dependent on vaccine type and anatomical site.
    Zeddeman A; van Schuppen E; Kok KE; van Gent M; Heuvelman KJ; Bart MJ; van der Heide HGJ; Gillard J; Simonetti E; Eleveld MJ; van Opzeeland FJH; van Selm S; de Groot R; de Jonge MI; Mooi FR; Diavatopoulos DA
    PLoS One; 2020; 15(8):e0237394. PubMed ID: 32822419
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pertussis Prevention: Reasons for Resurgence, and Differences in the Current Acellular Pertussis Vaccines.
    Esposito S; Stefanelli P; Fry NK; Fedele G; He Q; Paterson P; Tan T; Knuf M; Rodrigo C; Weil Olivier C; Flanagan KL; Hung I; Lutsar I; Edwards K; O'Ryan M; Principi N;
    Front Immunol; 2019; 10():1344. PubMed ID: 31333640
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of 13 acellular pertussis vaccines: overview and serologic response.
    Edwards KM; Meade BD; Decker MD; Reed GF; Rennels MB; Steinhoff MC; Anderson EL; Englund JA; Pichichero ME; Deloria MA
    Pediatrics; 1995 Sep; 96(3 Pt 2):548-57. PubMed ID: 7659475
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of adsorption of acellular pertussis antigens onto different aluminium salts on the protective activity in an intranasal murine model of Bordetella pertussis infection.
    Denoël P; Poolman J; Carletti G; Veitch K
    Vaccine; 2002 Jun; 20(19-20):2551-5. PubMed ID: 12057612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationships between functional assays and enzyme immunoassays as measurements of responses to acellular and whole-cell pertussis vaccines.
    Meade BD; Lynn F; Reed GF; Mink CM; Romani TA; Deforest A; Deloria MA
    Pediatrics; 1995 Sep; 96(3 Pt 2):595-600. PubMed ID: 7659484
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of co-purified acellular pertussis vaccines.
    Xu Y; Tan Y; Asokanathan C; Zhang S; Xing D; Wang J
    Hum Vaccin Immunother; 2015; 11(2):421-7. PubMed ID: 25610957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rapid increase in pertactin-deficient Bordetella pertussis isolates, Australia.
    Lam C; Octavia S; Ricafort L; Sintchenko V; Gilbert GL; Wood N; McIntyre P; Marshall H; Guiso N; Keil AD; Lawrence A; Robson J; Hogg G; Lan R
    Emerg Infect Dis; 2014 Apr; 20(4):626-33. PubMed ID: 24655754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The importance of Bordetella pertussis strains which do not produce virulence factors in the epidemiology of pertussis.
    Polak M; Lutyńska A
    Postepy Hig Med Dosw (Online); 2017 May; 71(0):367-379. PubMed ID: 28513461
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acellular pertussis vaccine for adolescents.
    de Carvalho AP; Pereira EM
    J Pediatr (Rio J); 2006 Jul; 82(3 Suppl):S15-24. PubMed ID: 16786100
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bordetella pertussis isolates in Finland after acellular vaccination: serotype change and biofilm formation.
    Niinikoski V; Barkoff AM; Mertsola J; He Q
    Clin Microbiol Infect; 2024 May; 30(5):683.e1-683.e3. PubMed ID: 38310999
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pertactin negative Bordetella pertussis demonstrates higher fitness under vaccine selection pressure in a mixed infection model.
    Safarchi A; Octavia S; Luu LD; Tay CY; Sintchenko V; Wood N; Marshall H; McIntyre P; Lan R
    Vaccine; 2015 Nov; 33(46):6277-81. PubMed ID: 26432908
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibody responses after primary immunization in infants born to women receiving a pertussis-containing vaccine during pregnancy: single arm observational study with a historical comparator.
    Ladhani SN; Andrews NJ; Southern J; Jones CE; Amirthalingam G; Waight PA; England A; Matheson M; Bai X; Findlow H; Burbidge P; Thalasselis V; Hallis B; Goldblatt D; Borrow R; Heath PT; Miller E
    Clin Infect Dis; 2015 Dec; 61(11):1637-44. PubMed ID: 26374816
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diphtheria-tetanus-acellular pertussis vaccine adsorbed (Triacelluvax; DTaP3-CB): a review of its use in the prevention of Bordetella pertussis infection.
    Matheson AJ; Goa KL
    Paediatr Drugs; 2000; 2(2):139-59. PubMed ID: 10937466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The induction of breast milk pertussis specific antibodies following gestational tetanus-diphtheria-acellular pertussis vaccination.
    Abu Raya B; Srugo I; Kessel A; Peterman M; Bader D; Peri R; Ashtamker N; Gonen R; Bamberger E
    Vaccine; 2014 Sep; 32(43):5632-7. PubMed ID: 25148774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Construction of Bordetella pertussis strains with enhanced production of genetically-inactivated Pertussis Toxin and Pertactin by unmarked allelic exchange.
    Buasri W; Impoolsup A; Boonchird C; Luengchaichawange A; Prompiboon P; Petre J; Panbangred W
    BMC Microbiol; 2012 Apr; 12():61. PubMed ID: 22524455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pertactin-negative Bordetella pertussis strains: evidence for a possible selective advantage.
    Martin SW; Pawloski L; Williams M; Weening K; DeBolt C; Qin X; Reynolds L; Kenyon C; Giambrone G; Kudish K; Miller L; Selvage D; Lee A; Skoff TH; Kamiya H; Cassiday PK; Tondella ML; Clark TA
    Clin Infect Dis; 2015 Jan; 60(2):223-7. PubMed ID: 25301209
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bordetella pertussis and pertactin-deficient clinical isolates: lessons for pertussis vaccines.
    Hegerle N; Guiso N
    Expert Rev Vaccines; 2014 Sep; 13(9):1135-46. PubMed ID: 24953157
    [TBL] [Abstract][Full Text] [Related]  

  • 39. One-year post-primary antibody persistence and booster immune response to a fully liquid five-component acellular pertussis, diphtheria, tetanus, inactivated poliomyelitis, Haemophilus influenzae type b conjugate vaccine.
    Lin TY; Wang YH; Huang YC; Chiu CH; Lin PY; Chen CJ; Chavand P; Ortiz E
    Int J Infect Dis; 2007 Nov; 11(6):488-95. PubMed ID: 17349809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessing the reactogenicity of Tdap vaccine administered during pregnancy and antibodies to Bordetella pertussis antigens in maternal and cord sera of Thai women.
    Wanlapakorn N; Maertens K; Chaithongwongwatthana S; Srimuan D; Suratannon N; Vongpunsawad S; Tran TMP; Hens N; Van Damme P; Locht C; Poovorawan Y; Leuridan E
    Vaccine; 2018 Mar; 36(11):1453-1459. PubMed ID: 29426663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.